Mark B. Schilling
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark B. Schilling.
Journal of Medicinal Chemistry | 2014
Romain Luc Marie Gosmini; Van Loc Nguyen; Jérôme Toum; Christophe Simon; Jean-Marie Brusq; Gael Krysa; Olivier Mirguet; Alizon M. Riou-Eymard; Eric Boursier; Lionel Trottet; Paul Bamborough; Hugh F. Clark; Chun-wa Chung; Leanne Cutler; Emmanuel Hubert Demont; Rejbinder Kaur; Antonia Lewis; Mark B. Schilling; Peter E. Soden; Simon Taylor; Ann Louise Walker; Matthew D. Walker; Rab K. Prinjha; Edwige Nicodeme
Through their function as epigenetic readers of the histone code, the BET family of bromodomain-containing proteins regulate expression of multiple genes of therapeutic relevance, including those involved in tumor cell growth and inflammation. BET bromodomain inhibitors have profound antiproliferative and anti-inflammatory effects which translate into efficacy in oncology and inflammation models, and the first compounds have now progressed into clinical trials. The exciting biology of the BETs has led to great interest in the discovery of novel inhibitor classes. Here we describe the identification of a novel tetrahydroquinoline series through up-regulation of apolipoprotein A1 and the optimization into potent compounds active in murine models of septic shock and neuroblastoma. At the molecular level, these effects are produced by inhibition of BET bromodomains. X-ray crystallography reveals the interactions explaining the structure-activity relationships of binding. The resulting lead molecule, I-BET726, represents a new, potent, and selective class of tetrahydroquinoline-based BET inhibitors.
Organic and Biomolecular Chemistry | 2004
W. Russell Bowman; Sussie L. Krintel; Mark B. Schilling
Tributylgermanium hydride (Bu(3)GeH) can be used as an alternative to tributyltin hydride (Bu(3)SnH) as a radical generating reagent with a wide range of radical substrates. Tributylgermanium hydride has several practical advantages over tributyltin hydride, e.g. low toxicity, good stability and much easier work-up of reactions. The reagent can be easily prepared in good yield and stored indefinitely. Suitable substrates include iodides, bromides, activated chlorides, phenyl selenides, tert-nitroalkanes, thiocarbonylimidazolides and Barton esters. Alkyl, vinyl and aryl radicals can be generated in radical reactions including reduction and cyclisation processes. Common radical initiators such as ACCN and triethylborane can be used. The slower rate of hydrogen abstraction by carbon-centred radicals from Bu(3)GeH as compared to Bu(3)SnH facilitates improved cyclisation yields. Polarity reversal catalysis (PRC) with phenylthiol can be used in reactions which generate stable radical intermediates which will not abstract hydrogen from Bu(3)GeH.
Tetrahedron Letters | 1995
Brian L. Bray; Simon Dolan; Bernard Charles Halter; J.William Lackey; Mark B. Schilling; David J. Tapolczay
Abstract Two methods for the stereospecific synthesis of the title compound are described. These short and efficient syntheses provide rapid access to this key intermediate in the construction of 2′-Deoxy Carbocyclic Nucleosides.
Tetrahedron Letters | 2003
Fiona M. Adam; Andrew J. Burton; Kevin S. Cardwell; Richard Cox; Richard A. Henson; Keith Mills; Jeremy C. Prodger; Mark B. Schilling; Daniel T. Tape
Abstract New syntheses of the amino-1,2,4-triazine, GW356194 have been developed to improve on existing methodology. The use of different amidrazones in cyclisations with α-keto and α-amido carbonyl compounds as the key step for the synthesis of the 1,2,4-triazine core was evaluated and the results are presented here.
Tetrahedron Letters | 2003
Andrew J. Burton; Kevin S. Cardwell; Matthew J. Fuchter; Mika Kristian Lindvall; Rajnikant Patel; Terry W. Packham; Jeremy C. Prodger; Mark B. Schilling; Matthew D. Walker
Unusual regiochemistry is observed in the products arising from the reaction of lithiated 1,2,4-trichlorobenzene with N,N-dimethylformamide and tetraalkyloxamides.
Journal of The Chemical Society-perkin Transactions 1 | 2000
Philip C. Bulman Page; Gerasimos A. Rassias; David Barros; Donald Bethell; Mark B. Schilling
A range of dihydroisoquinolinium salts has been prepared and tested as asymmetric epoxidation catalysts in an investigation of the reaction mechanism and the factors affecting enantioselectivity in this process.
Journal of Organic Chemistry | 1998
Philip C. Bulman Page; Gerasimos A. Rassias; Donald Bethell; Mark B. Schilling
Organic and Biomolecular Chemistry | 2004
W. Russell Bowman; Sussie L. Krintel; Mark B. Schilling
Synlett | 2004
W. Russell Bowman; Sussie L. Krintel; Mark B. Schilling
Organic Process Research & Development | 2010
Matthew D. Walker; Benjamin I. Andrews; Andrew J. Burton; Luke D. Humphreys; Gary Kelly; Mark B. Schilling; Peter W. Scott